Skip to main content
. Author manuscript; available in PMC: 2013 Apr 1.
Published in final edited form as: Curr Opin Allergy Clin Immunol. 2012 Apr;12(2):193–201. doi: 10.1097/ACI.0b013e32835090ac

Table 2.

Feature Adults (18 years+) with severe asthma
Children (6–17 years) with severe asthma
Observation {versus nonsevere asthma) Reference Observation (versus nonsevere asthma) Reference
Exacerbation severity Frequency emergency department visits and hospitalizations with ~30% hospitalized in the previous year; 20–25% with lifetime history of intubation [3] Frequent emergency department visits and hospitalizations with ~55% hospitalization in the previous year; 10–15% with lifetime history of intubation [2,42]

Allergic sensitization Varying degrees of atopy according to age of asthma onset and phenotype cluster [3,20▪▪] Highly atopic with increased peripheral blood eosinophilia, aeroallergen sensitivity, and elevated serum IgE concentrations [2,42.44▪▪]

Exhaled nitric oxide Not distinguishing overall but associated with exacerbations in a selected phenotype [3,45] Sustained elevations [2]

Airflow limitation Moderate-to-severe airflow limitation, often with incomplete reversal after bronchodilation [3,20▪▪,46] Some (mild) airflow limitation with near-complete reversal after bronchodilation; significant acceleration of airflow limitation in some adolescents after puberty [2,42,48▪▪]

Air trapping Increased air trapping (increased RV/TLC) at the same threshold of airflow limitation (FEV1/FVC) [46] Increased air trapping (increased RV/TLC) at baseline; reversible in girls but persistent in boys [2,47▪▪]

FEV1, forced expiratory volume in 1 s; FVC, forced vital capacity; RV/TLC, ratio of residual volume to total lung capacity.